This inventor holds 2 USPTO granted patents. Top assignee: Bayer Aktiengesellschaft. Active years: 1998-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2006
Title: Innovations by Roberto Correa in Viral Research
Introduction
Roberto Correa is a notable inventor based in Leverkusen, Germany. He has made significant contributions to the field of viral research, particularly in the development of vaccines and analytical methods for virus detection. With a total of 2 patents, his work has implications for both veterinary and medical science.
Latest Patents
One of his latest patents is focused on immunogenic peptides of foot-and-mouth disease viruses. This invention relates to a vaccine based on peptides that have a sequence of at least 8 amino acids, corresponding to a partial sequence of the non-structural protein region of FMDV. The peptides were selected based on their immunoreactivity with FMDV-specific antibodies or T lymphocytes, highlighting their potential use in vaccine development.
Another significant patent by Correa is a method for the analytical separation of viruses. This method allows for the non-destructive analytical detection and quantification of viruses or viral particles in a liquid sample matrix. The process utilizes capillary electrophoresis to separate viruses from other components in the sample, enabling accurate identification through spectroscopic interpretation.
Career Highlights
Roberto Correa is currently employed at Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. His work at Bayer has allowed him to focus on innovative solutions in viral research, contributing to advancements in vaccine technology and analytical methods.
Collaborations
Throughout his career, Correa has collaborated with esteemed colleagues such as Hans-Robert Hehnen and Hansjorg Durr. These collaborations have fostered a productive environment for research and innovation, enhancing the impact of their collective work in the field.
Conclusion
Roberto Correa's contributions to viral research through his patents and collaborations underscore his role as an influential inventor in the scientific community. His work continues to pave the way for advancements in vaccine development and virus detection methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile